1. Home
  2. DMN vs PIRS Comparison

DMN vs PIRS Comparison

Compare DMN & PIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DMN
  • PIRS
  • Stock Information
  • Founded
  • DMN 2020
  • PIRS 2001
  • Country
  • DMN Canada
  • PIRS United States
  • Employees
  • DMN N/A
  • PIRS N/A
  • Industry
  • DMN
  • PIRS Biotechnology: Pharmaceutical Preparations
  • Sector
  • DMN
  • PIRS Health Care
  • Exchange
  • DMN NYSE
  • PIRS Nasdaq
  • Market Cap
  • DMN 19.0M
  • PIRS 22.0M
  • IPO Year
  • DMN N/A
  • PIRS N/A
  • Fundamental
  • Price
  • DMN $0.63
  • PIRS N/A
  • Analyst Decision
  • DMN
  • PIRS
  • Analyst Count
  • DMN 0
  • PIRS 0
  • Target Price
  • DMN N/A
  • PIRS N/A
  • AVG Volume (30 Days)
  • DMN 681.0K
  • PIRS 21.2K
  • Earning Date
  • DMN 02-15-2025
  • PIRS 11-13-2024
  • Dividend Yield
  • DMN N/A
  • PIRS N/A
  • EPS Growth
  • DMN N/A
  • PIRS N/A
  • EPS
  • DMN N/A
  • PIRS N/A
  • Revenue
  • DMN N/A
  • PIRS $1,352,000.00
  • Revenue This Year
  • DMN N/A
  • PIRS N/A
  • Revenue Next Year
  • DMN N/A
  • PIRS N/A
  • P/E Ratio
  • DMN N/A
  • PIRS N/A
  • Revenue Growth
  • DMN N/A
  • PIRS N/A
  • 52 Week Low
  • DMN $0.63
  • PIRS $6.20
  • 52 Week High
  • DMN $4.95
  • PIRS $22.32
  • Technical
  • Relative Strength Index (RSI)
  • DMN N/A
  • PIRS 8.70
  • Support Level
  • DMN N/A
  • PIRS $16.24
  • Resistance Level
  • DMN N/A
  • PIRS $17.36
  • Average True Range (ATR)
  • DMN 0.00
  • PIRS 0.56
  • MACD
  • DMN 0.00
  • PIRS -1.70
  • Stochastic Oscillator
  • DMN 0.00
  • PIRS 0.00

About DMN DAMON INC

Damon Inc is a motorcycle manufacturing company that aims to transform the motorcycle industry by building a smart and technologically advanced motorcycle. Damon is developing technology and investing in capabilities to lead the industry in the transformation of the high-performance electric motorcycle market. It is introducing existing enthusiasts to high-performance electric products while bringing new riders to the motorcycle community with first-of-its-kind advances in zero-emissions motorcycle performance, safety, connectivity and AI.

About PIRS Pieris Pharmaceuticals Inc.

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store, and transport a wide spectrum of molecules. The Company's clinical pipeline consists of immuno-oncology, or IO, bispecifics in partnership with collaborators, including S095012 (also referred to as PRS-344) targeting PD-L1 and 4-1BB, SGN-BB228 (also referred to as PRS-346) targeting CD228 and 4-1BB, and BOS-342 (also referred to as PRS-342) targeting GPC3 and 4-1BB. Geographically, all the operations of the firm function through the region of the United States.

Share on Social Networks: